Accession Number: | 0001562180-18-003074 |
Date: | 2018-06-19 |
Issuer: | ARRAY BIOPHARMA INC (ARRY) |
Original Submission Date: |
SANDOR VICTOR
C/O ARRAY BIOPHARMA INC.
3200 WALNUT STREET
BOULDER, CO 80301
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2018-06-19 | M | 77,576 | a | $3.65 | 287,662 | direct | ||
COMMON STOCK | 2018-06-19 | S | 77,576 | d | $18.76 | 210,086 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 3.65 | 2018-06-19 | deemed execution date | M | 77,576 (d) | 2024-09-22 | common stock 77,576 | $3.65 | 279,259 | direct |
ID | footnote |
---|---|
f1 | these trades were made pursuant to a rule 10b5-1 trading plan. |
f2 | the price reported for these shares is the weighted average sale price of transactions made at prices from $18.75 to $18.845. details of actual prices for shares sold are available from the issuer upon request. |
f3 | the option vested in four equal annual installments beginning on september 22, 2015. |